Acadia Healthcare Company (ACHC) Stock Forecast, Price Target & Predictions
ACHC Stock Forecast
Acadia Healthcare Company stock forecast is as follows: an average price target of $84.89 (represents a 8.51% upside from ACHC’s last price of $78.23) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
ACHC Price Target
The average price target for Acadia Healthcare Company (ACHC) is $84.89 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $103.00 to $70.00. This represents a potential 8.51% upside from ACHC's last price of $78.23.
ACHC Analyst Ratings
According to 7 Wall Street analysts, Acadia Healthcare Company's rating consensus is 'Buy'. The analyst rating breakdown for ACHC stock is 0 'Strong Buy' (0.00%), 5 'Buy' (71.43%), 2 'Hold' (28.57%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Acadia Healthcare Company Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 01, 2024 | Andrew Mok | Barclays | $83.00 | $64.85 | 27.99% | 6.10% |
| May 22, 2024 | Frank Morgan | RBC Capital | $94.00 | $66.64 | 41.06% | 20.16% |
| May 03, 2024 | Ann Hynes | Mizuho Securities | $70.00 | $66.73 | 4.90% | -10.52% |
| Apr 25, 2024 | Pito Chickering | Deutsche Bank | $70.00 | $71.19 | -1.67% | -10.52% |
| Dec 12, 2022 | - | RBC Capital | $93.00 | $82.25 | 13.07% | 18.88% |
| Aug 26, 2022 | - | Leerink Partners | $103.00 | $85.23 | 20.85% | 31.66% |
| Aug 01, 2022 | - | RBC Capital | $94.00 | $82.91 | 13.38% | 20.16% |
| Aug 01, 2022 | - | Raymond James | $100.00 | $82.91 | 20.61% | 27.83% |
| Jul 29, 2022 | - | Mizuho Securities | $78.00 | $80.91 | -3.59% | -0.29% |
| Jul 29, 2022 | - | Barclays | $85.00 | $80.93 | 5.03% | 8.65% |
The latest Acadia Healthcare Company stock forecast, released on Aug 01, 2024 by Andrew Mok from Barclays, set a price target of $83.00, which represents a 27.99% increase from the stock price at the time of the forecast ($64.85), and a 6.10% increase from ACHC last price ($78.23).
Acadia Healthcare Company Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 4 |
| Avg Price Target | - | $83.00 | $79.25 |
| Last Closing Price | $78.23 | $78.23 | $78.23 |
| Upside/Downside | -100.00% | 6.10% | 1.30% |
In the current month, the average price target of Acadia Healthcare Company stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Acadia Healthcare Company's last price of $78.23. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 19, 2024 | RBC Capital | Hold | Hold | Hold |
| Aug 02, 2024 | RBC Capital | Buy | Buy | Hold |
| Aug 02, 2024 | Raymond James | Underperform | Underperform | Hold |
| Aug 01, 2024 | Barclays | Overweight | Overweight | Hold |
| Jul 02, 2024 | Mizuho Securities | Underperform | Underperform | Hold |
| Jul 02, 2024 | RBC Capital | Buy | Buy | Hold |
| Jun 18, 2024 | Cowen & Co. | Buy | Buy | Hold |
| May 22, 2024 | RBC Capital | Outperform | Outperform | Hold |
| May 17, 2024 | UBS | Buy | Buy | Hold |
| May 17, 2024 | RBC Capital | Underperform | Underperform | Hold |
Acadia Healthcare Company's last stock rating was published by RBC Capital on Aug 19, 2024. The company gave ACHC a "Hold" rating, the same as its previous rate.
Acadia Healthcare Company Financial Forecast
Acadia Healthcare Company Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $742.80M | $750.33M | $731.34M | $704.27M | $675.29M | $666.73M | - | $616.65M | $593.48M | $587.56M | $582.16M | $551.20M | $541.28M | $833.30M | $750.31M | $782.81M | $780.23M | $777.25M |
| Avg Forecast | $994.21M | $986.98M | $956.27M | $930.97M | $908.94M | $910.95M | $873.98M | $846.70M | $822.23M | $819.35M | $785.73M | $779.17M | $727.60M | $726.23M | $711.92M | $689.62M | $660.39M | $657.50M | $650.82M | $606.52M | $588.00M | $591.41M | $560.76M | $544.71M | $826.97M | $800.25M | $763.07M | $793.23M | $780.27M | $790.48M |
| High Forecast | $1.01B | $1.00B | $972.05M | $946.33M | $923.94M | $925.98M | $888.40M | $860.67M | $835.80M | $834.11M | $798.70M | $792.02M | $732.83M | $738.22M | $723.67M | $701.01M | $671.29M | $668.35M | $650.82M | $613.85M | $595.11M | $598.56M | $567.54M | $551.30M | $836.96M | $809.92M | $772.30M | $802.82M | $789.70M | $800.03M |
| Low Forecast | $981.06M | $973.92M | $943.62M | $918.65M | $896.91M | $898.89M | $862.41M | $835.50M | $811.35M | $809.70M | $775.33M | $768.85M | $723.49M | $716.62M | $702.50M | $680.50M | $651.65M | $648.80M | $650.82M | $597.88M | $579.63M | $582.99M | $552.78M | $536.95M | $815.19M | $788.85M | $752.21M | $781.93M | $769.15M | $779.22M |
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.03% | 1.03% | 1.02% | 1.02% | 1.01% | - | 1.02% | 1.01% | 0.99% | 1.04% | 1.01% | 0.65% | 1.04% | 0.98% | 0.99% | 1.00% | 0.98% |
Acadia Healthcare Company's average Quarter revenue forecast for Mar 24 based on 4 analysts is $779.17M, with a low forecast of $768.85M, and a high forecast of $792.02M. ACHC's average Quarter revenue forecast represents a 4.90% increase compared to the company's last Quarter revenue of $742.80M (Dec 23).
Acadia Healthcare Company EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $133.79M | $-235.45M | $148.10M | $137.21M | $137.62M | $144.68M | - | $124.03M | $143.75M | $127.05M | $106.18M | $69.84M | $-755.98M | $124.63M | $129.47M | $123.72M | $74.29M | $136.67M |
| Avg Forecast | $211.17M | $209.64M | $203.11M | $197.74M | $193.06M | $193.49M | $185.64M | $179.84M | $174.64M | $174.03M | $166.89M | $141.80M | $154.54M | $154.25M | $151.21M | $128.91M | $140.27M | $139.75M | $138.24M | $117.19M | $145.87M | $127.05M | $92.70M | $66.74M | $-643.13M | $92.32M | $84.15M | $110.69M | $71.26M | $144.12M |
| High Forecast | $214.66M | $213.10M | $206.47M | $201.00M | $196.25M | $196.68M | $188.70M | $182.81M | $177.53M | $177.17M | $169.65M | $170.16M | $155.66M | $156.80M | $153.71M | $154.69M | $142.58M | $167.70M | $138.24M | $140.63M | $175.04M | $152.46M | $111.24M | $80.09M | $-514.51M | $110.78M | $100.98M | $132.83M | $85.51M | $172.95M |
| Low Forecast | $208.38M | $206.86M | $200.43M | $195.12M | $190.51M | $190.93M | $183.18M | $177.46M | $172.33M | $171.98M | $164.68M | $113.44M | $153.67M | $152.21M | $149.21M | $103.13M | $138.41M | $111.80M | $138.24M | $93.75M | $116.70M | $101.64M | $74.16M | $53.39M | $-771.76M | $73.85M | $67.32M | $88.56M | $57.00M | $115.30M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.87% | -1.53% | 0.98% | 1.06% | 0.98% | 1.04% | - | 1.06% | 0.99% | 1.00% | 1.15% | 1.05% | 1.18% | 1.35% | 1.54% | 1.12% | 1.04% | 0.95% |
4 analysts predict ACHC's average Quarter EBITDA for Mar 24 to be $141.80M, with a high of $170.16M and a low of $113.44M. This is 5.98% upper than Acadia Healthcare Company's previous annual EBITDA (Dec 23) of $133.79M.
Acadia Healthcare Company Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $57.73M | $-217.71M | $72.30M | $66.02M | $61.12M | $71.10M | - | $60.84M | $71.52M | $66.13M | $44.51M | $9.72M | $-783.67M | $37.00M | $41.08M | $33.46M | $-11.25M | $42.57M |
| Avg Forecast | $105.39M | $109.28M | $106.75M | $93.33M | $93.59M | $97.73M | $94.16M | $81.54M | $79.91M | $82.90M | $80.66M | $70.16M | $72.95M | $82.09M | $78.94M | $63.78M | $68.98M | $72.74M | $71.58M | $57.99M | $76.31M | $66.13M | $38.86M | $9.29M | $-666.69M | $27.41M | $26.70M | $29.94M | $-10.79M | $44.89M |
| High Forecast | $107.65M | $111.63M | $109.04M | $95.33M | $95.60M | $99.83M | $96.18M | $83.29M | $81.63M | $84.74M | $82.39M | $84.19M | $75.69M | $83.85M | $80.63M | $76.54M | $70.46M | $87.29M | $71.58M | $69.58M | $91.57M | $79.35M | $46.63M | $11.14M | $-533.35M | $32.89M | $32.04M | $35.93M | $-8.64M | $53.87M |
| Low Forecast | $103.58M | $107.40M | $104.91M | $91.72M | $91.98M | $96.05M | $92.54M | $80.14M | $78.54M | $80.14M | $79.27M | $56.13M | $70.22M | $80.68M | $77.58M | $51.03M | $67.79M | $58.19M | $71.58M | $46.39M | $61.05M | $52.90M | $31.09M | $7.43M | $-800.03M | $21.92M | $21.36M | $23.95M | $-12.95M | $35.91M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.79% | -2.65% | 0.92% | 1.03% | 0.89% | 0.98% | - | 1.05% | 0.94% | 1.00% | 1.15% | 1.05% | 1.18% | 1.35% | 1.54% | 1.12% | 1.04% | 0.95% |
Acadia Healthcare Company's average Quarter net income forecast for Mar 24 is $70.16M, with a range of $56.13M to $84.19M. ACHC's average Quarter net income forecast represents a 21.54% increase compared to the company's last Quarter net income of $57.73M (Dec 23).
Acadia Healthcare Company SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $45.55M | $45.54M | $43.80M | $52.55M | $51.98M | $51.71M | - | $48.16M | $6.13M | $45.26M | $44.32M | $41.03M | $-88.25M | $82.54M | $79.44M | $524.44M | $513.54M | $510.89M |
| Avg Forecast | $78.21M | $77.64M | $75.22M | $73.23M | $71.50M | $71.66M | $68.75M | $66.60M | $64.68M | $64.45M | $61.81M | $55.54M | $57.23M | $57.13M | $56.00M | $50.49M | $51.95M | $49.79M | $51.19M | $45.90M | $6.22M | $45.26M | $38.69M | $39.21M | $-75.08M | $61.14M | $51.64M | $469.24M | $492.58M | $538.75M |
| High Forecast | $79.50M | $78.92M | $76.46M | $74.44M | $72.68M | $72.84M | $69.88M | $67.70M | $65.75M | $65.61M | $62.83M | $66.65M | $57.65M | $58.07M | $56.93M | $60.59M | $52.81M | $59.74M | $51.19M | $55.08M | $7.47M | $54.31M | $46.43M | $47.05M | $-60.06M | $73.37M | $61.96M | $563.08M | $591.10M | $646.50M |
| Low Forecast | $77.17M | $76.61M | $74.23M | $72.26M | $70.55M | $70.71M | $67.84M | $65.72M | $63.82M | $63.69M | $60.99M | $44.43M | $56.91M | $56.37M | $55.26M | $40.39M | $51.26M | $39.83M | $51.19M | $36.72M | $4.98M | $36.21M | $30.95M | $31.36M | $-90.10M | $48.91M | $41.31M | $375.39M | $394.07M | $431.00M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.80% | 0.80% | 0.78% | 1.04% | 1.00% | 1.04% | - | 1.05% | 0.99% | 1.00% | 1.15% | 1.05% | 1.18% | 1.35% | 1.54% | 1.12% | 1.04% | 0.95% |
Acadia Healthcare Company's average Quarter SG&A projection for Mar 24 is $55.54M, based on 4 Wall Street analysts, with a range of $44.43M to $66.65M. The forecast indicates a 21.95% rise compared to ACHC last annual SG&A of $45.55M (Dec 23).
Acadia Healthcare Company EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 5 | 3 | 6 | 4 | 6 | 10 | 10 | 10 | 10 | 10 | 9 | 9 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $0.63 | $-2.39 | $0.79 | $0.73 | $0.68 | $0.79 | - | $0.68 | $0.80 | $0.74 | $0.50 | $0.11 | $-8.91 | $0.42 | $0.47 | $0.38 | $-0.13 | $0.49 |
| Avg Forecast | $1.15 | $1.19 | $1.16 | $1.01 | $1.02 | $1.06 | $1.02 | $0.89 | $0.87 | $0.90 | $0.88 | $0.80 | $0.79 | $0.89 | $0.86 | $0.71 | $0.75 | $0.79 | $0.78 | $0.64 | $0.68 | $0.72 | $0.63 | $0.44 | $0.64 | $0.54 | $0.39 | $0.38 | $0.49 | $0.55 |
| High Forecast | $1.17 | $1.21 | $1.18 | $1.04 | $1.04 | $1.08 | $1.04 | $0.90 | $0.89 | $0.92 | $0.90 | $0.81 | $0.82 | $0.91 | $0.88 | $0.72 | $0.77 | $0.80 | $0.78 | $0.65 | $0.69 | $0.74 | $0.64 | $0.45 | $0.65 | $0.55 | $0.39 | $0.39 | $0.50 | $0.56 |
| Low Forecast | $1.13 | $1.17 | $1.14 | $1.00 | $1.00 | $1.04 | $1.01 | $0.87 | $0.85 | $0.87 | $0.86 | $0.78 | $0.76 | $0.88 | $0.84 | $0.70 | $0.74 | $0.77 | $0.78 | $0.62 | $0.67 | $0.71 | $0.62 | $0.44 | $0.62 | $0.53 | $0.38 | $0.37 | $0.48 | $0.54 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.79% | -2.68% | 0.92% | 1.03% | 0.91% | 1.00% | - | 1.07% | 1.17% | 1.02% | 0.80% | 0.25% | -14.02% | 0.78% | 1.21% | 1.00% | -0.26% | 0.89% |
According to 4 Wall Street analysts, Acadia Healthcare Company's projected average Quarter EPS for Mar 24 is $0.80, with a low estimate of $0.78 and a high estimate of $0.81. This represents a 26.50% increase compared to ACHC previous annual EPS of $0.63 (Dec 23).
Acadia Healthcare Company Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| AMED | Amedisys | $96.91 | $143.38 | 47.95% | Hold |
| EHAB | Enhabit | $8.10 | $10.25 | 26.54% | Hold |
| OPCH | Option Care Health | $31.99 | $38.00 | 18.79% | Buy |
| SEM | Select Medical | $35.23 | $40.00 | 13.54% | Buy |
| INNV | InnovAge | $5.99 | $6.80 | 13.52% | Hold |
| ACHC | Acadia Healthcare Company | $78.23 | $84.89 | 8.51% | Buy |
| EHC | Encompass Health | $93.25 | $93.17 | -0.09% | Buy |
| ADUS | Addus HomeCare | $130.13 | $123.00 | -5.48% | Buy |
| PNTG | Pennant Group | $34.52 | $30.67 | -11.15% | Buy |
| THC | Tenet Healthcare | $162.41 | $124.87 | -23.11% | Buy |
| DVA | DaVita | $163.56 | $125.50 | -23.27% | Hold |
| ENSG | Ensign Group | $152.73 | $114.25 | -25.19% | Buy |
| HCA | HCA Healthcare | $394.68 | $291.95 | -26.03% | Buy |
ACHC Forecast FAQ
Is Acadia Healthcare Company a good buy?
Yes, according to 7 Wall Street analysts, Acadia Healthcare Company (ACHC) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 71.43% of ACHC's total ratings.
What is ACHC's price target?
Acadia Healthcare Company (ACHC) average price target is $84.89 with a range of $70 to $103, implying a 8.51% from its last price of $78.23. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Acadia Healthcare Company stock go up soon?
According to Wall Street analysts' prediction for ACHC stock, the company can go up by 8.51% (from the last price of $78.23 to the average price target of $84.89), up by 31.66% based on the highest stock price target, and down by -10.52% based on the lowest stock price target.
Can Acadia Healthcare Company stock reach $120?
ACHC's average twelve months analyst stock price target of $84.89 does not support the claim that Acadia Healthcare Company can reach $120 in the near future.
What are Acadia Healthcare Company's analysts' financial forecasts?
Acadia Healthcare Company's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $3.54B (high $3.6B, low $3.49B), average EBITDA is $752.03M (high $764.44M, low $742.07M), average net income is $367.02M (high $374.9M, low $360.71M), average SG&A $278.51M (high $283.11M, low $274.82M), and average EPS is $3.99 (high $4.07, low $3.92). ACHC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $3.87B (high $3.93B, low $3.82B), average EBITDA is $821.66M (high $835.22M, low $810.79M), average net income is $414.75M (high $423.64M, low $407.61M), average SG&A $304.3M (high $309.32M, low $300.27M), and average EPS is $4.51 (high $4.6, low $4.43).
Did the ACHC's actual financial results beat the analysts' financial forecasts?
Based on Acadia Healthcare Company's last annual report (Dec 2023), the company's revenue was $2.93B, beating the average analysts forecast of $2.86B by 2.57%. Apple's EBITDA was $183.11M, missing the average prediction of $588.92M by -68.91%. The company's net income was $-21.667M, missing the average estimation of $297.77M by -107.28%. Apple's SG&A was $176.01M, missing the average forecast of $220.86M by -20.30%. Lastly, the company's EPS was $-0.24, missing the average prediction of $3.25 by -107.38%. In terms of the last quarterly report (Dec 2023), Acadia Healthcare Company's revenue was $742.8M, beating the average analysts' forecast of $727.6M by 2.09%. The company's EBITDA was $133.79M, missing the average prediction of $154.54M by -13.43%. Acadia Healthcare Company's net income was $57.73M, missing the average estimation of $72.95M by -20.87%. The company's SG&A was $45.54M, missing the average forecast of $57.23M by -20.42%. Lastly, the company's EPS was $0.63, missing the average prediction of $0.793 by -20.51%